Fluxergy is a healthcare technology company that provides a multimodal point-of-care diagnostic platform. Its system integrates molecular, immunoassay, cytometry, and clinical chemistry testing into a single, scalable, and affordable device.
Fluxergy is a biotechnology company based in Irvine, California, that provides a multimodal diagnostic platform designed for point-of-care testing. The company’s system integrates multiple diagnostic technologies—including molecular (PCR), immunochemistry, cytometry, and electrochemistry—onto a single, compact analyzer. Its proprietary test cards utilize a modular microfluidic chip design, allowing for versatility in testing applications while remaining cost-effective through automated, high-throughput manufacturing processes. The platform also includes FluxergyWorks, a middleware software solution that enables data management and seamless integration with Electronic Medical Record (EMR) and Laboratory Information Management (LIMS) systems.
By consolidating several diagnostic modalities into one platform, Fluxergy aims to deliver fast, accurate, and affordable health insights directly at the point of care. This approach is intended to empower clinicians and caregivers to make informed, real-time patient care decisions, helping to bridge the gap between complex laboratory testing and on-site clinical needs. Furthermore, the company offers its platform as an open OEM solution, partnering with developers to enable them to bring new assays to market more efficiently. With a 70,000-square-foot facility dedicated to technology innovation and microfluidic manufacturing, Fluxergy emphasizes scalable production capabilities to meet diagnostic demand.